toripalimab,gemcitabine,cisplatin,pemetrexed,pembrolizumab
junshi biosciences,merck,coherus
['neotorch', 'toripalimab', 'kn671', 'nsclc', 'sclc']
neotorch adds an option to the neoadjuvant setting in nsclc with toripalimab. survival eps tested hierarchically. kn671 in showed a glimpse of os benefit in a robust and well performed trial. now the encore to help consolidate ici prior to surgery. #asco23
Husband, Father.
Medical Oncologist and Researcher focused in Thoracic Oncology.
Views are my own.